Log in
RegisterBio waiver for lower strength (250mg) Mycophenolate mofetil tablet [Regulatives / Guidelines]
Hi,
Are the strengths formulation proportional? FDA or EMA?
FDA yes. Take a look at enalapril BE guidance.
J
❝ Please, I would like to know that, with the In vitro comparative dissolution study report can we waive off BE In vivo study with in vitro comparative dissolution study for the lower strength for Mycophenolate mofetil tablet 250mg or do we require separate BE study for the lower strength.
Are the strengths formulation proportional? FDA or EMA?
❝ And also I would like to know that whether similar approach can be taken for all the pro-drug where the metabolite of the drug is pharmacologically active.
FDA yes. Take a look at enalapril BE guidance.
J
Complete thread:
- Bio waiver for lower strength (250mg) Mycophenolate mofetil tablet Nidhiya J S 2019-11-05 06:14
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Bio waiver for lower strength (250mg) Mycophenolate mofetil tabletjag009 2019-11-07 19:52
- Bio waiver for lower strength (250mg) Mycophenolate mofetil tablet Nidhiya J S 2019-11-11 10:51
- Bio waiver for lower strength (250mg) Mycophenolate mofetil tablet wienui 2019-11-08 07:14
- Bio waiver for lower strength (250mg) Mycophenolate mofetil tablet Nidhiya J S 2019-11-11 10:51
- Bio waiver for lower strength (250mg) Mycophenolate mofetil tabletjag009 2019-11-07 19:52
Ing. Helmut Schütz